Fairmount Partners News: Fall 2017

Fairmount is the most active M&A firm based in the Mid-Atlantic, with a national and international practice.  Since 2003, the firm has completed more than 185 transactions throughout North and South America, Europe, Asia and Australia.   Fairmount specializes in advising middle-market companies on sell-side, buy-side and capital placement transactions, and provides fairness opinions and strategic advice in the transaction context.

  • Represented New England Research Institutes (NERI), a global, privately-held specialty Contract Research Organization providing customized clinical trial solutions and patient registry services to pharmaceutical, biotechnology, biomaterial and medical device companies, in its acquisition by HealthCore, Inc., the wholly-owned, independently operating health outcomes research subsidiary of Anthem (NYSE: ANTM).  Since its founding in 1986, NERI has earned widespread recognition for its scientific credibility, efficiency, and expertise in conducting clinical trials in a variety of medical specialties.  With over $85 billion in revenue, Anthem is one of the largest healthcare companies in the world.

 

  • Represented BioBridges, a Career Portfolio® Management company providing integrated services to the life sciences community, in its acquisition by The Adecco Group (VTX: ADEN) the world’s leading provider of workforce solutions.  Founded in 2005 and headquartered outside Boston, BioBridges is widely respected in the life sciences arena, managing the careers of highly skilled professionals who have extensive experience in the biotech, pharmaceutical and medical device industries.  The Adecco Group, based near Zurich, Switzerland, is the largest staffing firm in the world with annual revenue of over €28 billion, and a Fortune Global 500 company.

 

News for Fairmount Partners

August 2017: News

Fairmount is the most active M&A firm based in the Mid-Atlantic, with a national and international practice.  Since 2003, the firm has completed more than 185 transactions throughout North and South America, Europe, Asia and Australia.   Fairmount specializes in advising middle-market companies on sell-side, buy-side and capital placement transactions, and provides fairness opinions and strategic advice in the transaction context.

  • Represented ThreeWire®, the global leader in clinical trial recruitment and direct-to-patient marketing, in its acquisition by WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research.   ThreeWire® uses a systematic, patient-focused approach to help biopharmaceutical and medical device companies and clinical research organizations achieve their clinical trial enrollment and retention goals.  Having screened over 2 million patients in more than 25 countries, ThreeWire’s disciplined, proven approach consistently produces measurable, predictable results for its U.S. and overseas clients.
  • Represented Altasciences Company, Inc., a leading early phase contract research organization (CRO), in its acquisition by Audax Private Equity in partnership with Altasciences management. Audax acquired Altasciences from Kilmer Capital Partners, a private equity firm based in Toronto, Canada.  Altasciences, headquartered in Laval, Quebec, encompasses Algorithme Pharma, Vince & Associates Clinical Research, and Algorithme Pharma USA.  Altasciences offers expertise in the execution of a wide range of New Drug Application (NDA) enabling clinical trials and support services including data management, biostatistics, medical writing, and bioanalysis.

 

Fairmount Partners Spring News

Fairmount is the most active M&A firm based in the Mid-Atlantic, with a national and international practice.  Since 2003, the firm has completed more than 185 transactions throughout North and South America, Europe, Asia and Australia.   Fairmount specializes in advising middle-market companies on sell-side, buy-side and capital placement transactions, and provides fairness opinions and strategic advice in the transaction context.

  • Represented Artech Information Systems LLC, a provider of workforce solutions, IT consulting, and SOW-project services, in its acquisition of Tech-Pro, Inc., a Minneapolis, MN-based information technology solutions company.  Artech is a minority- and women-owned business enterprise (MWBE) headquartered in Morristown, NJ.  Artech employs over 7,200 professionals and maintains over 25 locations across the U.S., India, and China. Artech was founded in 1992 and today is a Tier-1/Preferred Supplier to more than 70 Fortune 500 companies and numerous federal and state government agencies.
  • Represented Teletronics Technology Corporation (“TTC”) “in a process that culminated in an announced sale for $233 mllion in cash to Curtiss-Wright Corporation (NYSE: CW),  a global innovative company that delivers highly engineered, critical function products and services to the commercial, industrial, defense and energy markets. TTC, a private company, is a leading designer and manufacturer of high-technology data acquisition and comprehensive flight test instrumentation systems for critical aerospace and defense applications. The acquired business will operate within Curtiss-Wright’s Defense segment, and completion of the transaction is expected in January, pending government approval.
  • Represented Collaborative Consulting, LLC in its sale to CGI Group Inc. (NYSE: GIB) (TSX: GIB.A).  Collaborative brings skills, experience and deep relationships in high-growth, in-demand IT services that improve usability, functionality and performance of digital technology and information management systems for its clients.  With a head office in Boston, MA and nearly 400 professionals, Collaborative generates annualized revenue of approximately $76 million.
  • Represented GroundLink in its acquisition by Marcou Transportation Group (“MTG”), the parent company of Dav El | BostonCoach.  GroundLink is a tech-enabled provider of executive black car service in major cities throughout the world. GroundLink has offices in North America and Europe, with its headquarters in New York, NY.  Dav El│BostonCoach is the largest privately owned chauffeured transportation company in the world. Marcou Transportation acquired GroundLink and software provider to the limousine industry, Limo Anywhere, to help MTG finalize its direct on-demand product for the corporate travel space.
  • Represented QS Pharma, a pharmaceutical contract development and manufacturing organization (CDMO) based in Philadelphia, in their sale to Quotient Clinical, an early phase drug development services company based in Nottingham, UK.  QS Pharma was owned by Charles River Laboratories (NYSE: CRL) who acquired the business as part of its 2016 acquisition of WIL Research.  Founded in 2002, QS Pharma specializes in the formulation development, analytical lab services, and manufacturing of small molecule drug products, from the early stages of development through to product commercialization.  Fairmount previously sold three businesses to Charles River Labs.
  • Represented Infusion, a global software engineering, design and digital strategy firm that delivers digital business transformation for the enterprise with strong Microsoft technology expertise, in their sale to Avanade, the leading provider of innovative digital and cloud services, business solutions and design-led experiences delivered through the power of people and the Microsoft ecosystem. Infusion, a major global software engineering and digital strategy firm, has 600 employees globally with offices in New York, Raleigh, Houston and London, and innovation centers in Toronto and in Wroclaw and Krakow, Poland, which expands Avanade’s operations in Europe. In addition to financial services companies, Infusion also serves clients in the oil & gas, retail, healthcare, education, and travel & leisure industries. “Infusion selected Fairmount Partners as its investment banking advisor because of the quality and depth of its historical relationships with firms like ours. The unique complexities of our successful transaction with Avanade/Accenture required a very strong investment banking team. Fairmount provided that and supported our Infusion team superbly throughout the entire process,” remarked DeBorah Brill, Co-Founder of Infusion.

News from Fairmount Partners

Fairmount Partners is an independent investment banking firm focused on serving the needs of middle market and emerging growth companies.  We provide a complete range of investment banking and capital advisory services for our clients including merger and acquisition advisory, financing advisory, fairness opinions and valuations and strategic corporate development advisory services.

  • Represented Teletronics Technology Corporation (“TTC”) “in a process that culminated in an announced sale for $233 mllion in cash to Curtiss-Wright Corporation (NYSE: CW),  a global innovative company that delivers highly engineered, critical function products and services to the commercial, industrial, defense and energy markets. TTC, a private company, is a leading designer and manufacturer of high-technology data acquisition and comprehensive flight test instrumentation systems for critical aerospace and defense applications. The acquired business will operate within Curtiss-Wright’s Defense segment, and completion of the transaction is expected in January, pending government approval.
  • Represented Electro-Science Laboratories, Inc. and a U.K.-based its affiliate  a leader in electronic packaging materials, in a process that resulted in the sale of ESL for $75 million tby Ferro Corporation (NYSE:FOE), a leading global functional coatings and color solutions company. ESL is a privately held company headquartered in King of Prussia, Pennsylvania.  Agmet Limited, the affiliate, is based in Reading, England.
  • In December, Nick Lopez joined Fairmount Partners as an analyst.  Prior to joining Fairmount, Mr. Lopez worked as an analyst at a boutique investment bank in the New York City area focused on  M&A advisory to middle-market technology and IT Services companies.  Mr. Lopez earned his B.S. in Finance with a minor in Economics and his M.B.A. with a concentration in Finance from St. Thomas Aquinas College. During this time, he was a full-scholarship basketball player and Scholar Athlete of the Year for the East Coast Conference two consecutive years.

Fairmount Partners News

Fairmount Partners is an independent investment banking firm focused on serving the needs of middle market and emerging growth companies. They provide a complete range of investment banking and capital advisory services for our clients including merger and acquisition advisory, financing advisory, fairness opinions and valuations and strategic corporate development advisory services.

  • Represented Avista Pharma Solutions, Inc.  in the sale of its Accuratus Lab Services operations to Microbiology Research Associates (MRA) of Acton, MA, a portfolio company of Thompson Street Capital Partners (TSCP). Accuratus, based outside Minneapolis, MN, is the leading provider of testing services for antimicrobial products that are regulated by the Environmental Protection Agency (EPA). The sale marks another successful strategic exit for Ampersand Capital Partners, the private equity owner of Avista Pharma, and allows Avista Pharma to focus on its core market in contract services to the pharmaceutical industry.
  • Represented ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, in the acquisition of Clinical Research Management (ClinicalRM), a full-service Contract Research Organization specializing in preclinical through Phase IV support of clinical research and clinical trial services for biologics, drugs and devices. Clinical RM specializes in government-sponsored research, and is a leader in infectious diseases, such as Ebola and Zika.  The acquisition will enhance ICON’s ability to access the market for government-sponsored research and further enhances ICON’s capabilities in the areas of vaccines and infectious diseases.  This was Fairmount’s 11th transaction with ICON.
  • Represented Agilux Laboratories, a Worcester, MA-based contract research organization (CRO), that provides a suite of integrated discovery small and large molecule bioanalytical services, drug metabolism and pharmacokinetic (DMPK) services, and pharmacology services in their acquisition by Charles River Laboratories International (NYSE: CRL), a global leader specializing in a variety of pre-clinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries.  The company’s unique combination of early-stage services enhances the flexibility and speed of its biopharmaceutical clients’ lead identification, optimization, and candidate selection efforts. Agilux was acquired from the company’s founders and Ampersand Capital Partners, its only institutional investor.  This was Fairmount’s fourth transaction for Ampersand Capital Partners, and third transaction with Charles River Labs.